In this review and commentary: This is an important issue in HIV management, and the results appear to show neither HIV nor HAART is associated with an enhanced risk of the metabolic syndrome. Medscape HIV/AIDS
How often does Kaposi sarcoma (KS)-associated herpesvirus (KSHV) infection occur in KS lesions in HIV+ and HIV- patients? How are human bcl-2, cleaved caspase-3 and KSHV LANA-1 in KS lesions expressed American Journal of Clinical Pathology
This review article outlines mechanisms of hepatotoxicity with ART and discusses preventive measures. Graphics show ARTs with safer liver profiles and highlight risks and predictors of liver toxicity. AIDS
In this trial, DAART provided on-treatment virologic benefit for HIV-infected drug users without affecting the rate of development of antiretroviral medication resistance. JAIDS: Journal of Acquired Immune Deficiency Syndromes
In this review and commentary: A look at using partner counseling and referral services as a means to increase identification of HIV-positive individuals. Medscape HIV/AIDS
In this review and commentary: Improvement in neuropsychiatric impairment over 96 weeks on HAART correlated with HIV RNA suppression in this ACTG trial substudy. Medscape HIV/AIDS
Although highly active antiretroviral therapy (HAART) significantly decreases viral levels in the cerebral spinal fluid of patients with HIV infection, even 4 or more years of HAART does not eliminate immunoactivation in the central nervous system (CNS), according to a recent study by Swedish and American researchers. Reuters Health Information
Using RNA interference to screen thousands of genes, a team of scientists from Boston has identified 273 human host proteins required for HIV propagation. The great majority of these HIV-dependency factors, or HDFs, has not been previously linked to HIV infection. Reuters Health Information
In this review and commentary: CD4+ cell count increases continue over 5 years of follow-up with HIV RNA less than 50 copies/mL on HAART. Medscape HIV/AIDS
In this review and commentary: Clinical trial of amphotericin B vs fluconazole in ART-naive or ART-experienced patients in South Africa. Medscape HIV/AIDS
